Mario Gabelli Amgen Inc Transaction History

Gamco Investors, Inc. Et Al

$8.56 Billion
Q2 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Amgen Inc stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 5,595 shares of AMGN stock, worth $1.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,595

Previous 5,431 3.02%

Holding current value

$1.8 Million

Previous $1.54 Million 13.21%

% of portfolio

0.02%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $43,091 - $52,366	164 Added 3.02%	5,595 $1.75 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $51,085 - $61,666	190 Added 3.63%	5,431 $1.54 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $99,485 - $123,514	-455 Reduced 7.99%	5,241 $1.41 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $27,426 - $32,431	128 Added 2.3%	5,696 $1.26 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $106,121 - $129,344	470 Added 9.22%	5,568 $1.35 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $3,435 - $4,365	15 Added 0.3%	5,098 $1.34 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $102,802 - $115,942	-458 Reduced 8.27%	5,083 $1.15 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $174,186 - $193,838	-755 Reduced 11.99%	5,541 $1.35 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $409,377 - $452,878	1,867 Added 42.15%	6,296 $1.52 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $16,904 - $19,346	85 Added 1.96%	4,429 $996,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $413,926 - $484,965	-1,950 Reduced 30.98%	4,344 $924,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $16,350 - $18,139	70 Added 1.12%	6,294 $1.53 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $380,131 - $442,981	1,713 Added 37.97%	6,224 $1.55 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $313,751 - $373,621	-1,450 Reduced 24.32%	4,511 $1.04 Million
Q3 2020 Nov 06, 2020	BUY	$234.65 - $260.95 $12,905 - $14,352	55 Added 0.93%	5,961 $1.52 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $75,167 - $92,241	-380 Reduced 6.05%	5,906 $1.39 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $12,756 - $16,919	70 Added 1.13%	6,286 $1.27 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $202,454 - $260,224	-1,070 Reduced 14.69%	6,216 $1.5 Million
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $216,244 - $259,106	1,242 Added 20.55%	7,286 $1.41 Million
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $18,837 - $22,081	113 Added 1.91%	6,044 $1.11 Million
Q4 2018 Jan 30, 2019	BUY	$178.4 - $208.25 $119,528 - $139,527	670 Added 12.74%	5,931 $1.16 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $24,077 - $27,043	-145 Reduced 2.68%	5,261 $971,000
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $11,012 - $12,870	65 Added 1.22%	5,406 $922,000
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $1.01 Million - $1.13 Million	-5,991 Reduced 52.87%	5,341 $929,000
Q3 2017 Nov 01, 2017	BUY	$167.29 - $191.0 $1.9 Million - $2.16 Million	11,332	11,332 $2.11 Million

Others Institutions Holding AMGN

# of Institutions

3,085

Shares Held

417M

Call Options Held

7.24M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account